Views & Analysis | Perspectives on pharma industry issues

Skip to main content

Wednesday 1 July 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

R&D

pharma manufacturing

Separating scientific risk assessment & consumer perception

In pharmaceutical development, conclusions are built on structured laboratory investigations and reproducible data, rather than simple classification.

Digital

HCP at laptop

Transitioning from CRM to intelligent engagement

Rolling out new systems is usually not the hardest part. The bigger shift lies in how engagement is structured and executed.

Market Access

Female consultants discuss

Sponsored

Company Profile: Acumetis

Acumetis is a global expert commercialisation partner purposefully built to help life sciences companies win in the age of connectivity.

R&D

pharma and biotech hiring

Changing Faces: Pharma and biotech hires, May 2026

Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.

R&D

pharmaphorum podcast Episode 266, Parexel - Paul Bridges and Charlotte Moser

Parexel: Flawless execution, policy shifts & patient-centric...

Parexel's Paul Bridges & Charlotte Moser discuss Europe's biotech sector in the face of an innovation cliff.

Oncology

Cancer cells

The cancer community must seize the opportunity of the Natio...

With the government’s National Cancer Plan due for publication this autumn, we have an opportunity to fundamentally improve how we deliver innovation.

R&D

Interview at LSX 2025 with Nikhil Mutyal

Driving innovation through partnership at AstraZeneca, with ...

Nikhil Mutyal, head of search and evaluation for respiratory and immunology at AstraZeneca, discusses partnership and external innovation at LSX.

Digital

12 Questions with Felix Faber

Sponsored

12 Questions with Felix Faber

Mindpeak's Felix Faber is an award-winning entrepreneur and computer scientist with a track record of founding companies.

Load more results

Sales & Marketing

Sales & Marketing

Pharmacist reads doctor's notes with AI overlay concept in pharmacy

How pharma can make pharmacies a powerful marketing channel

Among POC marketing strategies, activating the pharmacy environment is especially powerful.

Sales & Marketing

12 Questions with Shauna Lord

Sponsored

12 Questions with Shauna Lord

Shauna Lord recently joined GSK as Business Unit Head Specialty (UK Commercial) to lead the Specialty business in the UK.

Digital

Digital

HCP at laptop

Transitioning from CRM to intelligent engagement

Rolling out new systems is usually not the hardest part. The bigger shift lies in how engagement is structured and executed.

Digital

Oslo, Norway

How a Norwegian hospital unlocked capacity without adding st...

The question for healthcare leaders is less whether AI has a role in surgical planning, and more how to implement it best.

Market Access

Market Access

Female consultants discuss

Sponsored

Company Profile: Acumetis

Acumetis is a global expert commercialisation partner purposefully built to help life sciences companies win in the age of connectivity.

Market Access

Agile business

Why 70% of pharma partnership spend misses patients

Finding a start-up or building an app is the cheap part; combining capabilities into something that scales across markets is the expensive part.

Editor's Picks

Lilly launches its LillyDirect sales channel in the UK

HHS details plan to regain the US's edge in clinical trials

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

EFPIA report adds to pressures on EU drug pricing policy

Obesity is rising fastest in young adults in England

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

ASCO 2026: Three ADC approvals in five days, with Ken Keller and John Tsai

ASCO 2026: Three ADC approvals in five days, with Ken Keller...

At ASCO 26, Daiichi Sankyo leaders Ken Keller and John Tsai chatted with pharmaphorum about their big year of oncology launches, halfway in.

Oncology

ASCO 2026: Can a blood test spot cancer early? with Dr Peter Sasieni

ASCO 2026: Can a blood test spot cancer early? with Dr Peter...

Dr Peter Sasieni, co-investigator for the NHS Galleri trial, discusses advances in population-level blood screening for early cancer detection.

Oncology

CAR-T has a geography problem

The gap between what CAR-T can do and who can actually get it is the defining challenge of this field right now.

Patients

Patients

PSP services

Sponsored

Designing global PSPs for the real world

How integrating strategic design with implementation expertise can help create more scalable, locally relevant, and effective global PSPs.

Patients

group of women

Is women’s health reaching an inflection point?

A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.

Patients

Patient engagement and support

Patient engagement drives clinical and commercial success

Engagement solutions can tap into long-lasting patient motivations that sustain behaviour.

R&D

R&D

pharma manufacturing

Separating scientific risk assessment & consumer perception

In pharmaceutical development, conclusions are built on structured laboratory investigations and reproducible data, rather than simple classification.

R&D

pharma and biotech hiring

Changing Faces: Pharma and biotech hires, May 2026

Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.

R&D

pharmaphorum podcast Episode 266, Parexel - Paul Bridges and Charlotte Moser

Parexel: Flawless execution, policy shifts & patient-centric...

Parexel's Paul Bridges & Charlotte Moser discuss Europe's biotech sector in the face of an innovation cliff.

Editor's Picks

Lilly launches its LillyDirect sales channel in the UK

HHS details plan to regain the US's edge in clinical trials

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

EFPIA report adds to pressures on EU drug pricing policy

Obesity is rising fastest in young adults in England

News

Ipsen's M&A team strikes again, adding Memo in $700m deal

Ipsen's M&A team strikes again, adding Memo in $700m deal

Ipsen will pay up to €700m to take control of Memo Therapeutics and its drug for BK polyomavirus, which can lead to the failure of kidney transplants.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company